Home › Funds › BENDER ROBERT & ASSOCIATES › ABBV

BENDER ROBERT & ASSOCIATES position in ABBV

ABBVIE INC · Health Care

BENDER ROBERT & ASSOCIATES reported holding 3,251 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$850K, representing 0.16% of its reported portfolio and ranking #29 among its reported holdings. BENDER ROBERT & ASSOCIATES has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.25K sh
Reported value held$850.43K
Portfolio Weight0.16%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BENDER ROBERT & ASSOCIATES's ABBV position evolved

BENDER ROBERT & ASSOCIATES first disclosed a stake in ABBV in Q3 2023 at 12,884 shares (US$1.9M). Across 13 filings, BENDER ROBERT & ASSOCIATES increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,251 shares valued at US$850K — an increase of 858 shares quarter over quarter.. Notable position changes include a 29% trim in Q4 2023 (shares rose 19% over the following quarter), a 42% trim in Q3 2024 (shares fell 9% over the following quarter), a 36% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.88K $1.92M New
Q4 2023 9.16K $1.42M Reduce
Q1 2024 8.52K $1.55M Reduce
Q2 2024 7.47K $1.28M Reduce
Q3 2024 4.33K $854.89K Reduce
Q4 2024 4.30K $763.58K Reduce
Q1 2025 3.36K $704.83K Reduce
Q2 2025 3.33K $618.49K Reduce
Q3 2025 2.98K $690.45K Reduce
Q4 2025 2.76K $630.17K Reduce
Q1 2026 2.39K $520.45K Reduce
Q2 2026 2.39K $602.17K Hold
Q3 2026 3.25K $850.43K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has BENDER ROBERT & ASSOCIATES held ABBV?

BENDER ROBERT & ASSOCIATES has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BENDER ROBERT & ASSOCIATES's current position in ABBV?

As of Q3 2026, BENDER ROBERT & ASSOCIATES holds 3.25K shares of ABBV (ABBVIE INC), valued at $850.43K, representing 0.16% of its reported portfolio and ranking #29.

Has BENDER ROBERT & ASSOCIATES been buying or selling ABBV?

In the latest 13F filing (Q3 2026), BENDER ROBERT & ASSOCIATES increased its position in ABBV.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.